Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $7.0 million.

  • Q32 Bio's Non-Current Assets fell 3447.95% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.7 million, marking a year-over-year decrease of 4973.78%. This contributed to the annual value of $10.5 million for FY2024, which is 8595.91% down from last year.
  • As of Q3 2025, Q32 Bio's Non-Current Assets stood at $7.0 million, which was down 3447.95% from $7.8 million recorded in Q2 2025.
  • Q32 Bio's Non-Current Assets' 5-year high stood at $228.7 million during Q4 2022, with a 5-year trough of $7.0 million in Q3 2025.
  • Moreover, its 5-year median value for Non-Current Assets was $38.0 million (2023), whereas its average is $41.0 million.
  • In the last 5 years, Q32 Bio's Non-Current Assets skyrocketed by 105457.8% in 2022 and then crashed by 8595.91% in 2024.
  • Over the past 5 years, Q32 Bio's Non-Current Assets (Quarter) stood at $19.8 million in 2021, then skyrocketed by 1054.58% to $228.7 million in 2022, then plummeted by 67.45% to $74.5 million in 2023, then crashed by 85.96% to $10.5 million in 2024, then tumbled by 33.3% to $7.0 million in 2025.
  • Its Non-Current Assets stands at $7.0 million for Q3 2025, versus $7.8 million for Q2 2025 and $10.4 million for Q1 2025.